Paper Details 
Original Abstract of the Article :
Neurogenic lower urinary tract dysfunction (NLUTD) in children can cause renal failure and urinary incontinence if not treated sufficiently. Antimuscarinics (AM) and intradetrusor botulinum toxin injections (BoNT-A) with clean intermittent catheterization (CIC) are widely used treatment options for ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jpurol.2023.08.015

データ提供:米国国立医学図書館(NLM)

Mirabegron: A Promising Treatment for Refractory Neurogenic Lower Urinary Tract Dysfunction (NLUTD) in Children

Neurogenic lower urinary tract dysfunction (NLUTD) in children can significantly impact their quality of life. This study evaluates the effectiveness of mirabegron, a medication used to treat overactive bladder, as a treatment option for children with refractory NLUTD. The researchers aimed to assess the efficacy and long-term outcomes of mirabegron in children with NLUTD, both as an add-on therapy and as a stand-alone treatment.

Mirabegron: A Potential Solution for Refractory NLUTD

The study provides evidence that mirabegron may be a valuable treatment option for children with refractory NLUTD. The researchers found that mirabegron was effective in managing symptoms and improving long-term outcomes in these patients.

Improving the Lives of Children with NLUTD

This research holds promise for improving the lives of children with refractory NLUTD. By offering an effective treatment option, we can help these children regain control of their bladder function and lead more fulfilling lives. It's like finding a hidden oasis in the desert, offering a refreshing solution to a challenging condition.

Dr.Camel's Conclusion

This research offers a ray of hope for children struggling with refractory NLUTD. Like a desert traveler discovering a well, mirabegron has the potential to alleviate symptoms and improve the quality of life for these children. This study underscores the importance of continuous research and development in finding effective treatment options for complex pediatric conditions.

Date :
  1. Date Completed n.d.
  2. Date Revised 2023-12-07
Further Info :

Pubmed ID

37658014

DOI: Digital Object Identifier

10.1016/j.jpurol.2023.08.015

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.